Anagrelide-13C2,15N,d2

CAS: F: C913C2H8D2Cl2N15NO W: 262.11

Anagrelide-13C2,15N,d2 is 15N and deuterated labeled Anagrelide (HY-B0523). Anagrelide is a potent inhibitor of phosphod

Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity	Anagrelide-13C2,15N,d2 is 15N and deuterated labeled Anagrelide (HY-B0523). Anagrelide is a potent inhibitor of phosphodiesterase type III (PDE3) (IC50=36?nM). Anagrelide, an imidazoquinazoline derivative, acts as an inhibitor of platelet aggregation. Anagrelide inhibits bone marrow megakaryocytopoiesis. Anagrelide decreases gastrointestinal stromal tumor (GIST) cell proliferation and promotes their apoptosis in vitro. Anagrelide is a platelet-lowering agent and plays in the antithrombopoietic action[1][2][3].
Invitro	氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。Anagrelide 有效抑制骨髓巨核细胞的发育 (IC50=26?nM)[2]。Anagrelide (0.05、0.3、1 μM；12 天) 仅抑制巨核细胞生长，不抑制非巨核细胞生长[3]。Anagrelide (0.1-10000 nM) 在 GIST882 细胞系中诱导细胞毒性作用[4]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Anagrelide-13C2,15N,d2 相关抗体:
In Vivo	Anagrelide (5 mg/kg/bid；持续 10 天) 抑制或减少 GIST2B、GIST9、GIST882 模型中的肿瘤生长[4]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Formula	C913C2H8D2Cl2N15NO
Molar Mass	262.11
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Guosu Wang, et al. Comparison of the biological activities of Anagrelide and its major metabolites in haematopoietic cell cultures. Br J Pharmacol. 2005 Oct;146(3):324-32. [3]. Y Hong, et al. Comparison between Anagrelide and hydroxycarbamide in their activities against haematopoietic progenitor cell growth and differentiation: selectivity of Anagrelide for the megakaryocytic lineage. Leukemia. 2006 Jun;20(6):1117-22. [4]. Olli-Pekka Pulkka, et al. Anagrelide for Gastrointestinal Stromal Tumor. Clin Cancer Res. 2019 Mar 1;25(5):1676-1687.

2-Sec-butyl-3-methoxypyrazine-d3

6-Octen-1,1-d2-1-ol, 3,7-dimethyl-